Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Br J Pharmacol
2004 Dec 01;1438:1050-7. doi: 10.1038/sj.bjp.0705944.
Show Gene links
Show Anatomy links
Identification of R(-)-isomer of efonidipine as a selective blocker of T-type Ca2+ channels.
Furukawa T
,
Miura R
,
Honda M
,
Kamiya N
,
Mori Y
,
Takeshita S
,
Isshiki T
,
Nukada T
.
???displayArticle.abstract???
Efonidipine, a derivative of dihydropyridine Ca(2+) antagonist, is known to block both L- and T-type Ca(2+) channels. It remains to be clarified, however, whether efonidipine affects other voltage-dependent Ca(2+) channel subtypes such as N-, P/Q- and R-types, and whether the optical isomers of efonidipine have different selectivities in blocking these Ca(2+) channels, including L- and T-types. To address these issues, the effects of efonidipine and its R(-)- and S(+)-isomers on these Ca(2+) channel subtypes were examined electrophysiologically in the expression systems using Xenopus oocytes and baby hamster kidney cells (BHK tk-ts13). Efonidipine, a mixture of R(-)- and S(+)-isomers, exerted blocking actions on L- and T-types, but no effects on N-, P/Q- and R-type Ca(2+) channels. The selective blocking actions on L- and T-type channels were reproduced by the S(+)-efonidipine isomer. By contrast, the R(-)-efonidipine isomer preferentially blocked T-type channels. The blocking actions of efonidipine and its enantiomers were dependent on holding potentials. These findings indicate that the R(-)-isomer of efonidipine is a specific blocker of the T-type Ca(2+) channel.
Andreasen,
The alpha(1G)-subunit of a voltage-dependent Ca(2+) channel is localized in rat distal nephron and collecting duct.
2000, Pubmed
Andreasen,
The alpha(1G)-subunit of a voltage-dependent Ca(2+) channel is localized in rat distal nephron and collecting duct.
2000,
Pubmed
Cannon,
Regulation of calcium channel activity by lipid domain formation in planar lipid bilayers.
2003,
Pubmed
Cribbs,
Molecular cloning and functional expression of Ca(v)3.1c, a T-type calcium channel from human brain.
2000,
Pubmed
Fujita,
Primary structure and functional expression of the omega-conotoxin-sensitive N-type calcium channel from rabbit brain.
1993,
Pubmed
Furukawa,
Selectivities of dihydropyridine derivatives in blocking Ca(2+) channel subtypes expressed in Xenopus oocytes.
1999,
Pubmed
,
Xenbase
Furukawa,
Voltage and pH dependent block of cloned N-type Ca2+ channels by amlodipine.
1997,
Pubmed
,
Xenbase
Furukawa,
Differential interactions of the C terminus and the cytoplasmic I-II loop of neuronal Ca2+ channels with G-protein alpha and beta gamma subunits. II. Evidence for direct binding.
1998,
Pubmed
,
Xenbase
Hamill,
Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches.
1981,
Pubmed
Harada,
Clinical efficacy of efonidipine hydrochloride, a T-type calcium channel inhibitor, on sympathetic activities.
2003,
Pubmed
Hayashi,
Role of actions of calcium antagonists on efferent arterioles--with special references to glomerular hypertension.
2003,
Pubmed
Hering,
Ca2+ channel block and inactivation: common molecular determinants.
1998,
Pubmed
Hermsmeyer,
Physiologic and pathophysiologic relevance of T-type calcium-ion channels: potential indications for T-type calcium antagonists.
1997,
Pubmed
Hockerman,
Molecular determinants of drug binding and action on L-type calcium channels.
1997,
Pubmed
Hullin,
Calcium channel beta subunit heterogeneity: functional expression of cloned cDNA from heart, aorta and brain.
1992,
Pubmed
,
Xenbase
Krayenbühl,
Drug-drug interactions of new active substances: mibefradil example.
1999,
Pubmed
Lee,
Cloning and expression of a novel member of the low voltage-activated T-type calcium channel family.
1999,
Pubmed
,
Xenbase
Marksteiner,
Inactivation determinants in segment IIIS6 of Ca(v)3.1.
2001,
Pubmed
,
Xenbase
Martínez,
Expression of T-type Ca(2+) channels in ventricular cells from hypertrophied rat hearts.
1999,
Pubmed
Mason,
Membrane interaction of calcium channel antagonists modulated by cholesterol. Implications for drug activity.
1993,
Pubmed
Masumiya,
Effects of Ca2+ channel antagonists on sinus node: prolongation of late phase 4 depolarization by efonidipine.
1997,
Pubmed
Masumiya,
Inhibition of myocardial L- and T-type Ca2+ currents by efonidipine: possible mechanism for its chronotropic effect.
1998,
Pubmed
Mikami,
Primary structure and functional expression of the cardiac dihydropyridine-sensitive calcium channel.
1989,
Pubmed
,
Xenbase
Mishra,
Selective inhibition of T-type Ca2+ channels by Ro 40-5967.
1994,
Pubmed
Monteil,
Molecular and functional properties of the human alpha(1G) subunit that forms T-type calcium channels.
2000,
Pubmed
Mori,
Primary structure and functional expression from complementary DNA of a brain calcium channel.
1991,
Pubmed
,
Xenbase
Nakamura,
G protein-mediated inhibition of phosphoinositide metabolism evoked by metabotropic glutamate receptors in frog oocytes.
1994,
Pubmed
,
Xenbase
Niidome,
Molecular cloning and characterization of a novel calcium channel from rabbit brain.
1992,
Pubmed
Perez-Reyes,
Molecular physiology of low-voltage-activated t-type calcium channels.
2003,
Pubmed
Perez-Reyes,
Molecular characterization of a neuronal low-voltage-activated T-type calcium channel.
1998,
Pubmed
,
Xenbase
Sakoda,
Synthesis and crystal structure of optically active 2-[benzyl(phenyl)amino]ethyl 5-(5,5-dimethyl-2-oxo-1,3,2-dioxaphosphorinan-2-yl)-1,4-dihydro-2,6-dim ethyl-4-(3-nitrophenyl)-3-pyridinecarboxylate (NZ-105).
1992,
Pubmed
Sen,
T-type Ca2+ channels are abnormal in genetically determined cardiomyopathic hamster hearts.
1994,
Pubmed
Striessnig,
Structural basis of drug binding to L Ca2+ channels.
1998,
Pubmed
Talavera,
Temperature sensitive mutants of BHK cells affected in cell cycle progression.
1977,
Pubmed
Tanaka,
Efonidipine hydrochloride: a dual blocker of L- and T-type ca(2+) channels.
2002,
Pubmed
Triggle,
1,4-Dihydropyridine activators and antagonists: structural and functional distinctions.
1989,
Pubmed
Uneyama,
Blockade of N-type Ca2+ current by cilnidipine (FRC-8653) in acutely dissociated rat sympathetic neurones.
1997,
Pubmed
Van der Vring,
T-channel-selective calcium channel blockade: a promising therapeutic possibility, only preliminarily tested so far: a review of published data. T-Channel Calcium Channel Blocker Study Group.
1999,
Pubmed
Wada,
A region of the sulfonylurea receptor critical for a modulation of ATP-sensitive K(+) channels by G-protein betagamma-subunits.
2000,
Pubmed
Wakamori,
Single tottering mutations responsible for the neuropathic phenotype of the P-type calcium channel.
1998,
Pubmed